SynCore Biotechnology Co.,Ltd announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 3.932 million compared to TWD 2.039 million a year ago. Operating loss was TWD 100.151 million compared to TWD 112.738 million a year ago. Net loss was TWD 101.990 million compared to TWD 110.785 million a year ago. Basic loss per share was TWD 0.96 compared to TWD 1.22 a year ago. For the nine months, sales was TWD 7.672 million compared to TWD 10.841 million a year ago. Operating loss was TWD 294.698 million compared to TWD 300.773 million a year ago. Net loss was TWD 296.260 million compared to TWD 296.367 million a year ago. Basic loss per share was TWD 2.87 compared to TWD 3.38 a year ago.